Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: think out of the box!
Sign Up to like & getrecommendations! Published in 2019 at "Metabolism: clinical and experimental"
DOI: 10.1016/j.metabol.2019.154001
Abstract: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in Western societies and a major cause of hepatic disease worldwide. Its more severe type, namely nonalcoholic steatohepatitis (NASH), may result in the… read more here.
Keywords: antidiabetic drugs; fatty liver; effects newer; disease ... See more keywords